139 related articles for article (PubMed ID: 23158942)
1. Effects of Chinese medicine for promoting blood circulation and removing blood stasis in treating patients with mild to moderate vascular dementia: a randomized, double-blind and parallel-controlled trial.
Wei MQ; Tian JZ; Shi J; Ma FY; Miao YC; Wang YY
Zhong Xi Yi Jie He Xue Bao; 2012 Nov; 10(11):1240-6. PubMed ID: 23158942
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of Fufangdanshen tablets (Radix Salviae miltiorrhizae formula tablets) for mild to moderate vascular dementia: a study protocol for a randomized controlled trial.
Tian J; Shi J; Wei M; Qin R; Ni J; Zhang X; Li T; Wang Y
Trials; 2016 Jun; 17(1):281. PubMed ID: 27266867
[TBL] [Abstract][Full Text] [Related]
3. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial.
Miao YC; Tian JZ; Shi J; Mao M
Zhong Xi Yi Jie He Xue Bao; 2012 Apr; 10(4):390-7. PubMed ID: 22500712
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of a multicenter, phase 2 clinical trial to investigate the efficacy of traditional Chinese medicine SaiLuoTong in vascular dementia.
Liang J; Li F; Wei C; Song H; Wu L; Tang Y; Jia J
J Stroke Cerebrovasc Dis; 2014; 23(10):2626-2634. PubMed ID: 25294055
[TBL] [Abstract][Full Text] [Related]
5. Donepezil for vascular cognitive impairment.
Malouf R; Birks J
Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
[TBL] [Abstract][Full Text] [Related]
6. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
De Jesus Moreno Moreno M
Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
[TBL] [Abstract][Full Text] [Related]
7. Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study.
Weyer G; Eul A; Milde K; Wierich W; Herrmann WM
Pharmacopsychiatry; 2000 May; 33(3):89-97. PubMed ID: 10855459
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of Tianmabianchunzhigan in mild to moderate vascular dementia: Protocol of a randomized controlled IIa trial.
Tian J; Shi J; Wei M; Li T; Ni J; Zhang X; Zhang M; Li Y; Wang Y
Medicine (Baltimore); 2018 Dec; 97(51):e13760. PubMed ID: 30572524
[TBL] [Abstract][Full Text] [Related]
9. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of Shenmayizhi decoction as an adjuvant treatment for vascular dementia: Study protocol for a randomized controlled trial.
Wang H; Liu N; Wei Y; Pei H; Liu M; Diao X; Zhang H; Li H
Medicine (Baltimore); 2019 Dec; 98(50):e18326. PubMed ID: 31852125
[TBL] [Abstract][Full Text] [Related]
11. [A clinical study on a randomized, double-blind control of Chinese medicine granules in treatment of vascular dementia].
Zhu AH; Tian JZ; Zhong J; Yang CZ; Shi J; Yin JX
Zhongguo Zhong Yao Za Zhi; 2006 Oct; 31(20):1722-5. PubMed ID: 17225547
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Guilingji Capsules () for Treating Mild-to-Moderate Cognitive Impairment: Study Protocol for A Randomized, Double-Blind, Positive-Controlled, Multicenter and Noninferiority Trial.
Liu NY; Pei H; Liu MX; Liu LT; Fu CG; Li H; Chen KJ
Chin J Integr Med; 2020 Aug; 26(8):577-582. PubMed ID: 32761337
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).
Wilcock G; Möbius HJ; Stöffler A;
Int Clin Psychopharmacol; 2002 Nov; 17(6):297-305. PubMed ID: 12409683
[TBL] [Abstract][Full Text] [Related]
14. [Clinical curative effect of Shenxiong Bushen Capsule and its effect on the quality of life of patients with Vascular dementia].
Guo MD; Zhou WQ; Wei Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):593-7. PubMed ID: 20815273
[TBL] [Abstract][Full Text] [Related]
15. Galantamine treatment of vascular dementia: a randomized trial.
Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer's disease: protocol for a randomized controlled trial.
Chua KK; Wong A; Kwan PW; Song JX; Chen LL; Chan AL; Lu JH; Mok V; Li M
Trials; 2015 Apr; 16():199. PubMed ID: 25925312
[TBL] [Abstract][Full Text] [Related]
17. An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia.
Erkinjuntti T; Kurz A; Small GW; Bullock R; Lilienfeld S; Damaraju CV;
Clin Ther; 2003 Jun; 25(6):1765-82. PubMed ID: 12860497
[TBL] [Abstract][Full Text] [Related]
18. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials.
Román GC; Wilkinson DG; Doody RS; Black SE; Salloway SP; Schindler RJ
Dement Geriatr Cogn Disord; 2005; 20(6):338-44. PubMed ID: 16192723
[TBL] [Abstract][Full Text] [Related]
19. Effect and Safety of Huannao Yicong Formula () in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Double-Blinded, Donepezil-Controlled Trial.
Yang Y; Liu JP; Fang JY; Wang HC; Wei Y; Cao Y; Liu JG; Liu LT; Li H
Chin J Integr Med; 2019 Aug; 25(8):574-581. PubMed ID: 30109588
[TBL] [Abstract][Full Text] [Related]
20. Rivastigmine for vascular cognitive impairment.
Birks J; McGuinness B; Craig D
Cochrane Database Syst Rev; 2013 May; (5):CD004744. PubMed ID: 23728651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
